首页 | 本学科首页   官方微博 | 高级检索  
     


Butanedione treatment reduces receptor binding of a lysosomal enzyme to cells and membranes
Authors:Leonard H. Rome  Jonothan Miller
Affiliation:Genetics and Biochemistry Branch National Institute of Arthritis, Metabolism and Digestive Diseases Bethesda, MD 20205 USA
Abstract:Treatment of the lysosomal enzyme, α-L-iduronidase, with 2,3 butanedione, an arginine modifying reagent, under conditions where enzyme activity was unaffected, reduced by 50% the internalization of the enzyme into cultured human fibroblasts. The lowered rate of internalization was a result of a reduced binding of the enzyme to cell surface receptors. The butanedione treatment of α-L-iduronidase caused a 90% reduction of binding when isolated fibroblast membranes were used as the source of receptor. This marked reduction of binding was also seen when membranes from a rat chondrosarcoma were examined. Although there is ample evidence that the receptor recognizes mannose 6-phosphate residues on the enzyme, the results suggest that other structural features, such as arginine moieties, may also be important in iduronidase binding.
Keywords:To whom inquiries and requests for reprints should be addressed. Present address: The Department of Biological Chemistry   UCLA School of Medicine   University of California   Los Angeles   California 90024.
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号